Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00404911 · ClinicalTrials.gov registry record · NA
Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
NCT00404911: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00404911 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 416 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00404911, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
Study Summary
This study will examine the effectiveness of a multiple family group mental health service delivery strategy in improving mental health service use and outcome for urban, low income children of color, ages 7-11 years old with disruptive behaviors and their families.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL MFG therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2006-10 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT00404911 record still lists
NCT00404911 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT00404911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00404911 about?
NCT00404911 is a clinical study titled "Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth". This study will examine the effectiveness of a multiple family group mental health service delivery strategy in improving mental health service use and outcome for urban, low income children of color, ages 7-11 years old with disruptive behaviors and their families.
What is the current status of trial NCT00404911?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2006-10. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00404911?
The interventions under investigation include: Standard of Care (BEHAVIORAL), MFG therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00404911?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00404911's enrollment target sits among peer trials
416 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia